Actinogen Medical

Actinogen Medical Limited (ACW, formerly Actinogen Limited) is an ASX-listed biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes. It focusses on the development of Xanamem, a novel treatment for Alzheimer's disease and the cognitive deficiency associated with other neurological and metabolic diseases within Australia.

Contact Details

Suite 901, Level 9 , 109 Pitt St SYDNEY NSW 2000

02 8964 7401

info@actinogen.com.au

www.actinogen.com.au

Lists and Charts

Share price

Actinogen Medical
Closing price for the last 90 trading days

View ASX Chart

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
625^th	/Company/Aquirian	14.29%	0%
626^th	/Company/Globe-International	14.18%	27.3%
627^th	/Company/Actinogen-Medical	14.13%	-8.42%
628^th	/Company/Central-Petroleum	13.97%	-20.17%
629^th	/Company/Alterity-Therapeutics	13.95%	-30.54%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

Company Activity

	NEW ROLE: William Souter,	02 Dec 2024
	NEWS: Tagged in Coking coal elbows antimony sideways to take centre stage	30 Aug 2024
	NEWS: Tagged in New money sends InteliCare share price flying	28 Jun 2024
	NEW ROLE: Dana Hilt,	04 Sep 2023
	NEW ROLE: Paul Rolan,	03 Jan 2023
	NEW ROLE: Steven Gourlay, Chief Executive Officer, Managing Director	13 Apr 2022
	NEW ROLE: Jeff Carter,	01 Mar 2022
	NEW ROLE: Tamara Miller,	01 Mar 2022
	REMUNERATION UPDATE: Malcolm McComas, Non-Executive Director	03 Nov 2020

News Articles

Related Information

Access to our data for Actinogen Medical is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Actinogen Medical is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today